3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
CNS
1
Conditions
Brain Neoplasms
12
Central Nervous System Neoplasms
11
Glioblastoma
10
Gliosarcoma
8
Glioma
7
Astrocytoma
4
Oligodendroglioma
3
Neuroblastoma
3
Melanoma
3
Medulloblastoma
3
Sarcoma
2
Recurrence
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive
2
Neoplasms
2
Ependymoma
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Interventions
Filgrastim
8
Granulocyte Colony-Stimulating Factor
7
Thiotepa
6
Etoposide
5
Carboplatin
5
Peripheral Blood Stem Cell Transplantation
4
Cyclophosphamide
4
Busulfan
4
Melphalan
3
Ifosfamide
3
Topotecan
2
Mesna
2
sargramostim
1
racotumomab
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
etoposide phosphate
1
cixutumumab
1
becatecarin
1
alvocidib
1
Vincristine
1
Ursodeoxycholic Acid
1
Thrombopoietin
1
Thalidomide
1
Temozolomide
1
Stem Cell Transplantation
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinoblastoma
×
Thalidomide
×
CNS
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled